rs4755228

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBA1

The NM_207122.2(EXT2):​c.28C>A​(p.Arg10Arg) variant causes a synonymous change. The variant allele was found at a frequency of 0.0156 in 1,614,126 control chromosomes in the GnomAD database, including 1,714 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.019 ( 240 hom., cov: 32)
Exomes 𝑓: 0.015 ( 1474 hom. )

Consequence

EXT2
NM_207122.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 5.73

Publications

11 publications found
Variant links:
Genes affected
EXT2 (HGNC:3513): (exostosin glycosyltransferase 2) This gene encodes one of two glycosyltransferases involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type II form of multiple exostoses. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jul 2008]
EXT2 Gene-Disease associations (from GenCC):
  • exostoses, multiple, type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, G2P
  • seizures-scoliosis-macrocephaly syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
  • hereditary multiple osteochondromas
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.16).
BP6
Variant 11-44107740-C-A is Benign according to our data. Variant chr11-44107740-C-A is described in ClinVar as Benign. ClinVar VariationId is 195445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.268 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EXT2NM_207122.2 linkc.28C>A p.Arg10Arg synonymous_variant Exon 2 of 14 ENST00000533608.7 NP_997005.1 Q93063-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EXT2ENST00000533608.7 linkc.28C>A p.Arg10Arg synonymous_variant Exon 2 of 14 1 NM_207122.2 ENSP00000431173.2 Q93063-1

Frequencies

GnomAD3 genomes
AF:
0.0192
AC:
2925
AN:
152134
Hom.:
242
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00454
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0315
Gnomad ASJ
AF:
0.00577
Gnomad EAS
AF:
0.280
Gnomad SAS
AF:
0.0599
Gnomad FIN
AF:
0.0157
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00447
Gnomad OTH
AF:
0.0120
GnomAD2 exomes
AF:
0.0354
AC:
8899
AN:
251388
AF XY:
0.0343
show subpopulations
Gnomad AFR exome
AF:
0.00511
Gnomad AMR exome
AF:
0.0355
Gnomad ASJ exome
AF:
0.00714
Gnomad EAS exome
AF:
0.282
Gnomad FIN exome
AF:
0.0150
Gnomad NFE exome
AF:
0.00432
Gnomad OTH exome
AF:
0.0186
GnomAD4 exome
AF:
0.0153
AC:
22314
AN:
1461874
Hom.:
1474
Cov.:
32
AF XY:
0.0161
AC XY:
11688
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.00349
AC:
117
AN:
33480
American (AMR)
AF:
0.0353
AC:
1579
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00627
AC:
164
AN:
26136
East Asian (EAS)
AF:
0.251
AC:
9946
AN:
39698
South Asian (SAS)
AF:
0.0455
AC:
3923
AN:
86258
European-Finnish (FIN)
AF:
0.0148
AC:
790
AN:
53410
Middle Eastern (MID)
AF:
0.00555
AC:
32
AN:
5768
European-Non Finnish (NFE)
AF:
0.00401
AC:
4461
AN:
1112004
Other (OTH)
AF:
0.0216
AC:
1302
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
1256
2513
3769
5026
6282
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
362
724
1086
1448
1810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0192
AC:
2925
AN:
152252
Hom.:
240
Cov.:
32
AF XY:
0.0219
AC XY:
1627
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.00452
AC:
188
AN:
41548
American (AMR)
AF:
0.0316
AC:
483
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00577
AC:
20
AN:
3468
East Asian (EAS)
AF:
0.280
AC:
1448
AN:
5170
South Asian (SAS)
AF:
0.0603
AC:
291
AN:
4824
European-Finnish (FIN)
AF:
0.0157
AC:
166
AN:
10600
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00447
AC:
304
AN:
68024
Other (OTH)
AF:
0.0118
AC:
25
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
133
265
398
530
663
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00848
Hom.:
195
Bravo
AF:
0.0208
Asia WGS
AF:
0.132
AC:
457
AN:
3478
EpiCase
AF:
0.00463
EpiControl
AF:
0.00379

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Exostoses, multiple, type 2 Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Oct 20, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Exostoses, multiple, type 1 Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.16
CADD
Benign
13
DANN
Benign
0.67
PhyloP100
5.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4755228; hg19: chr11-44129290; COSMIC: COSV59149768; COSMIC: COSV59149768; API